The assessment of risk factors and treatment of pulmonary TB relapses Source: Eur Respir J 2006; 28: Suppl. 50, 129s Year: 2006
The risk of ineffective MDR/XDR TB treatment, based on bedaquilin: factors and their influence Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Study of risk factors in relapses at patients with pulmonary tuberculosis. Their retreatment results Source: Eur Respir J 2001; 18: Suppl. 33, 467s Year: 2001
COVID-19 prevalence, risk factors and outcomes in COPD Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
The risk factors of the TB death among case of initial treatment failure and retreatment after default Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012
The clinical features and the risk factors of teenagers cases with MDR-TB in Romania Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Treatment outcome and risk factors of death in elderly patients diagnosed as new cases of tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010
The risk factors in asthma patients for COVID19 infection Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Smoking is a risk factor for TB infection, but is it an additional mortality risk? Source: Annual Congress 2011 - Management of tuberculosis Year: 2011
The influence of the epidemic risk factor on advanced processes in adolescents with newly-detected pulmonary TB Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007
Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016
Survival and risk factors of mortality among defaulters from treatment of pulmonary tuberculosis Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012
Using community pharmacy to identify patients at risk of poor asthma control and potential contributory factors Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011
The problem of early mortality in pneumococcal pneumonia: a study of risk factors Source: Eur Respir J 2015; 46: 561-564 Year: 2015
Risk factors for paradoxical response during adequate tuberculosis treatment Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005
The standardised treatment of pulmonary TB: outcomes, problems and suggestions Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties Year: 2005
How does current knowledge on primarily hereditary risk factors for asthma and other lung diseases improve prevention, treatment and prognosis? Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine Year: 2012
Knowledge and attitudes of TB patients about risk factors which contribute the genesis of their disease Source: Eur Respir J 2005; 26: Suppl. 49, 417s Year: 2005
Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation Source: Eur Respir J 2011; 38: 749-751 Year: 2011
Incidence and specific risk factors of falling in pulmonary rehabilitation Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention Year: 2010